Aerospace & Defense
Compare Stocks
5 / 10Stock Comparison
CDRE vs MSA vs HON vs AXON vs MMM
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Conglomerates
Aerospace & Defense
Conglomerates
CDRE vs MSA vs HON vs AXON vs MMM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Aerospace & Defense | Security & Protection Services | Conglomerates | Aerospace & Defense | Conglomerates |
| Market Cap | $1.26B | $6.59B | $135.04B | $32.51B | $74.74B |
| Revenue (TTM) | $610M | $1.92B | $36.76B | $2.98B | $25.02B |
| Net Income (TTM) | $44M | $291M | $4.10B | $206M | $2.79B |
| Gross Margin | 42.5% | 46.8% | 36.9% | 59.3% | 39.5% |
| Operating Margin | 12.3% | 22.0% | 14.9% | 1.3% | 19.6% |
| Forward P/E | 24.2x | 19.2x | 20.2x | 52.5x | 16.5x |
| Total Debt | $322M | $627M | $34.58B | $1.91B | $12.94B |
| Cash & Equiv. | $123M | $165M | $12.49B | $1.20B | $5.24B |
CDRE vs MSA vs HON vs AXON vs MMM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | 100 | 147.3 | +47.3% |
| MSA Safety Incorpor… (MSA) | 100 | 118.6 | +18.6% |
| Honeywell Internati… (HON) | 100 | 105.4 | +5.4% |
| Axon Enterprise, In… (AXON) | 100 | 239.1 | +139.1% |
| 3M Company (MMM) | 100 | 100.8 | +0.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDRE vs MSA vs HON vs AXON vs MMM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDRE is the clearest fit if your priority is growth exposure.
- Rev growth 7.5%, EPS growth 13.3%, 3Y rev CAGR 10.1%
MSA carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.92, Low D/E 45.9%, current ratio 3.01x
- PEG 1.09 vs HON's 11.03
- Lower P/E (19.2x vs 52.5x)
- 15.2% margin vs AXON's 6.9%
HON is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 15 yrs, beta 0.74, yield 2.2%
- Beta 0.74, yield 2.2%, current ratio 1.32x
- Beta 0.74 vs CDRE's 1.47
- 2.2% yield, 15-year raise streak, vs CDRE's 1.2%, (1 stock pays no dividend)
AXON ranks third and is worth considering specifically for long-term compounding.
- 20.7% 10Y total return vs MSA's 290.0%
- 33.5% revenue growth vs MMM's 1.5%
Among these 5 stocks, MMM doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 33.5% revenue growth vs MMM's 1.5% | |
| Value | Lower P/E (19.2x vs 52.5x) | |
| Quality / Margins | 15.2% margin vs AXON's 6.9% | |
| Stability / Safety | Beta 0.74 vs CDRE's 1.47 | |
| Dividends | 2.2% yield, 15-year raise streak, vs CDRE's 1.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +9.2% vs AXON's -41.2% | |
| Efficiency (ROA) | 11.4% ROA vs AXON's 3.1%, ROIC 17.9% vs -1.3% |
CDRE vs MSA vs HON vs AXON vs MMM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CDRE vs MSA vs HON vs AXON vs MMM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HON leads in 2 of 6 categories
CDRE leads 1 • MSA leads 1 • AXON leads 1 • MMM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MSA and AXON each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 60.2x CDRE's $610M. MSA is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to AXON's 6.9%. On growth, AXON holds the edge at +33.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $610M | $1.9B | $36.8B | $3.0B | $25.0B |
| EBITDAEarnings before interest/tax | $94M | $496M | $6.5B | $97M | $5.2B |
| Net IncomeAfter-tax profit | $44M | $291M | $4.1B | $206M | $2.8B |
| Free Cash FlowCash after capex | $57M | $309M | $4.2B | $20M | $2.1B |
| Gross MarginGross profit ÷ Revenue | +42.5% | +46.8% | +36.9% | +59.3% | +39.5% |
| Operating MarginEBIT ÷ Revenue | +12.3% | +22.0% | +14.9% | +1.3% | +19.6% |
| Net MarginNet income ÷ Revenue | +7.2% | +15.2% | +11.2% | +6.9% | +11.1% |
| FCF MarginFCF ÷ Revenue | +9.3% | +16.1% | +11.4% | +0.7% | +8.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.0% | +10.0% | -6.9% | +33.7% | +1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -15.6% | +21.2% | -41.9% | +89.8% | -39.7% |
Valuation Metrics
CDRE leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 23.9x trailing earnings, MMM trades at a 91% valuation discount to AXON's 267.2x P/E. Adjusting for growth (PEG ratio), MSA offers better value at 1.37x vs HON's 15.77x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.3B | $6.6B | $135.0B | $32.5B | $74.7B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $7.1B | $157.1B | $33.2B | $82.4B |
| Trailing P/EPrice ÷ TTM EPS | 29.26x | 23.97x | 28.96x | 267.25x | 23.88x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.15x | 19.21x | 20.24x | 52.50x | 16.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.37x | 15.77x | — | — |
| EV / EBITDAEnterprise value multiple | 15.51x | 14.89x | 19.75x | 1575.65x | 15.15x |
| Price / SalesMarket cap ÷ Revenue | 2.06x | 3.51x | 3.61x | 11.70x | 3.00x |
| Price / BookPrice ÷ Book value/share | 4.08x | 4.89x | 8.87x | 12.44x | 16.27x |
| Price / FCFMarket cap ÷ FCF | 22.14x | 22.30x | 25.04x | 433.05x | 53.54x |
Profitability & Efficiency
MSA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MMM delivers a 65.3% return on equity — every $100 of shareholder capital generates $65 in annual profit, vs $7 for AXON. MSA carries lower financial leverage with a 0.46x debt-to-equity ratio, signaling a more conservative balance sheet compared to MMM's 2.73x. On the Piotroski fundamental quality scale (0–9), MSA scores 6/9 vs MMM's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.5% | +22.0% | +23.1% | +6.6% | +65.3% |
| ROA (TTM)Return on assets | +5.9% | +11.4% | +5.3% | +3.1% | +7.5% |
| ROICReturn on invested capital | +11.9% | +17.9% | +12.6% | -1.3% | +28.1% |
| ROCEReturn on capital employed | +12.3% | +19.2% | +12.6% | -1.5% | +16.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.01x | 0.46x | 2.24x | 0.59x | 2.73x |
| Net DebtTotal debt minus cash | $199M | $462M | $22.1B | $709M | $7.7B |
| Cash & Equiv.Liquid assets | $123M | $165M | $12.5B | $1.2B | $5.2B |
| Total DebtShort + long-term debt | $322M | $627M | $34.6B | $1.9B | $12.9B |
| Interest CoverageEBIT ÷ Interest expense | 6.34x | 12.70x | 3.92x | 1.69x | 6.52x |
Total Returns (Dividends Reinvested)
AXON leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AXON five years ago would be worth $31,282 today (with dividends reinvested), compared to $9,465 for MMM. Over the past 12 months, MSA leads with a +9.2% total return vs AXON's -41.2%. The 3-year compound annual growth rate (CAGR) favors AXON at 22.1% vs HON's 4.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.9% | +5.1% | +9.4% | -28.4% | -11.0% |
| 1-Year ReturnPast 12 months | -17.1% | +9.2% | +1.5% | -41.2% | +3.6% |
| 3-Year ReturnCumulative with dividends | +49.1% | +30.1% | +14.7% | +81.9% | +80.1% |
| 5-Year ReturnCumulative with dividends | +106.0% | +7.9% | +1.0% | +212.8% | -5.4% |
| 10-Year ReturnCumulative with dividends | +106.0% | +290.0% | +132.4% | +2074.2% | +32.2% |
| CAGR (3Y)Annualised 3-year return | +14.2% | +9.2% | +4.7% | +22.1% | +21.7% |
Risk & Volatility
HON leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than CDRE's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HON currently trades 85.9% from its 52-week high vs AXON's 45.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.47x | 0.92x | 0.74x | 1.06x | 1.04x |
| 52-Week HighHighest price in past year | $48.76 | $208.92 | $248.18 | $885.92 | $177.41 |
| 52-Week LowLowest price in past year | $27.33 | $151.10 | $186.76 | $339.01 | $139.21 |
| % of 52W HighCurrent price vs 52-week peak | +61.2% | +81.3% | +85.9% | +45.6% | +80.8% |
| RSI (14)Momentum oscillator 0–100 | 44.9 | 52.4 | 44.2 | 55.9 | 44.0 |
| Avg Volume (50D)Average daily shares traded | 419K | 210K | 3.7M | 1.0M | 3.5M |
Analyst Outlook
HON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CDRE as "Buy", MSA as "Buy", HON as "Buy", AXON as "Buy", MMM as "Hold". Consensus price targets imply 72.5% upside for CDRE (target: $52) vs 14.4% for HON (target: $244). For income investors, HON offers the higher dividend yield at 2.17% vs CDRE's 1.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $51.50 | $222.33 | $243.83 | $653.89 | $166.75 |
| # AnalystsCovering analysts | 9 | 11 | 28 | 21 | 33 |
| Dividend YieldAnnual dividend ÷ price | +1.2% | +1.2% | +2.2% | — | +1.5% |
| Dividend StreakConsecutive years of raises | 2 | 12 | 15 | — | 0 |
| Dividend / ShareAnnual DPS | $0.36 | $2.09 | $4.63 | — | $2.18 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% | +2.8% | 0.0% | +6.4% |
HON leads in 2 of 6 categories (Risk & Volatility, Analyst Outlook). CDRE leads in 1 (Valuation Metrics). 1 tied.
CDRE vs MSA vs HON vs AXON vs MMM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CDRE or MSA or HON or AXON or MMM a better buy right now?
For growth investors, Axon Enterprise, Inc.
(AXON) is the stronger pick with 33. 5% revenue growth year-over-year, versus 1. 5% for 3M Company (MMM). 3M Company (MMM) offers the better valuation at 23. 9x trailing P/E (16. 5x forward), making it the more compelling value choice. Analysts rate Cadre Holdings, Inc. (CDRE) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDRE or MSA or HON or AXON or MMM?
On trailing P/E, 3M Company (MMM) is the cheapest at 23.
9x versus Axon Enterprise, Inc. at 267. 2x. On forward P/E, 3M Company is actually cheaper at 16. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: MSA Safety Incorporated wins at 1. 09x versus Honeywell International Inc. 's 11. 03x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CDRE or MSA or HON or AXON or MMM?
Over the past 5 years, Axon Enterprise, Inc.
(AXON) delivered a total return of +212. 8%, compared to -5. 4% for 3M Company (MMM). Over 10 years, the gap is even starker: AXON returned +20. 7% versus MMM's +32. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDRE or MSA or HON or AXON or MMM?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Cadre Holdings, Inc. 's 1. 47β — meaning CDRE is approximately 99% more volatile than HON relative to the S&P 500. On balance sheet safety, MSA Safety Incorporated (MSA) carries a lower debt/equity ratio of 46% versus 3% for 3M Company — giving it more financial flexibility in a downturn.
05Which is growing faster — CDRE or MSA or HON or AXON or MMM?
By revenue growth (latest reported year), Axon Enterprise, Inc.
(AXON) is pulling ahead at 33. 5% versus 1. 5% for 3M Company (MMM). On earnings-per-share growth, the picture is similar: Cadre Holdings, Inc. grew EPS 13. 3% year-over-year, compared to -68. 5% for Axon Enterprise, Inc.. Over a 3-year CAGR, AXON leads at 32. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDRE or MSA or HON or AXON or MMM?
MSA Safety Incorporated (MSA) is the more profitable company, earning 14.
9% net margin versus 4. 5% for Axon Enterprise, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSA leads at 21. 4% versus -2. 2% for AXON. At the gross margin level — before operating expenses — AXON leads at 59. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CDRE or MSA or HON or AXON or MMM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, MSA Safety Incorporated (MSA) is the more undervalued stock at a PEG of 1. 09x versus Honeywell International Inc. 's 11. 03x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, 3M Company (MMM) trades at 16. 5x forward P/E versus 52. 5x for Axon Enterprise, Inc. — 36. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CDRE: 72. 5% to $51. 50.
08Which pays a better dividend — CDRE or MSA or HON or AXON or MMM?
In this comparison, HON (2.
2% yield), MMM (1. 5% yield), MSA (1. 2% yield), CDRE (1. 2% yield) pay a dividend. AXON does not pay a meaningful dividend and should not be held primarily for income.
09Is CDRE or MSA or HON or AXON or MMM better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 2% yield, +132. 4% 10Y return). Both have compounded well over 10 years (HON: +132. 4%, AXON: +20. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CDRE and MSA and HON and AXON and MMM?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CDRE is a small-cap quality compounder stock; MSA is a small-cap quality compounder stock; HON is a mid-cap quality compounder stock; AXON is a mid-cap high-growth stock; MMM is a mid-cap quality compounder stock. CDRE, MSA, HON, MMM pay a dividend while AXON does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.